- Home
- CUE vs USEG Comparison
CUE vs USEG Comparison
Compare CUE & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- USEG
- Stock Information
- Founded
- CUE 2014
- USEG 1966
- Country
- CUE United States
- USEG United States
- Employees
- CUE N/A
- USEG N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- USEG Oil & Gas Production
- Sector
- CUE Health Care
- USEG Energy
- Exchange
- CUE Nasdaq
- USEG Nasdaq
- Market Cap
- CUE 48.0M
- USEG 42.2M
- IPO Year
- CUE 2018
- USEG N/A
- Fundamental
- Price
- CUE $0.75
- USEG $1.33
- Analyst Decision
- CUE Strong Buy
- USEG Strong Buy
- Analyst Count
- CUE 3
- USEG 1
- Target Price
- CUE $3.00
- USEG $3.50
- AVG Volume (30 Days)
- CUE 308.2K
- USEG 9.4M
- Earning Date
- CUE 08-13-2025
- USEG 08-06-2025
- Dividend Yield
- CUE N/A
- USEG N/A
- EPS Growth
- CUE N/A
- USEG N/A
- EPS
- CUE N/A
- USEG N/A
- Revenue
- CUE $7,991,000.00
- USEG $16,340,000.00
- Revenue This Year
- CUE N/A
- USEG $23.82
- Revenue Next Year
- CUE $23.84
- USEG N/A
- P/E Ratio
- CUE N/A
- USEG N/A
- Revenue Growth
- CUE 13.83
- USEG N/A
- 52 Week Low
- CUE $0.45
- USEG $0.81
- 52 Week High
- CUE $1.99
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- CUE 57.89
- USEG 45.77
- Support Level
- CUE $0.65
- USEG $1.31
- Resistance Level
- CUE $0.88
- USEG $1.69
- Average True Range (ATR)
- CUE 0.07
- USEG 0.18
- MACD
- CUE 0.01
- USEG -0.05
- Stochastic Oscillator
- CUE 62.51
- USEG 3.13
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.